Crossmark

C-reactive protein-triglyceride glucose index in evaluating cardiovascular disease and all-cause mortality incidence among individuals across stages 0–3 of cardiovascular–kidney–metabolic syndrome: a nationwide prospective cohort study

Crossref DOI link: https://doi.org/10.1186/s12933-025-02848-9

Published Online: 2025-07-22

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ou, Huiwen

Wei, Miaomiao

Li, Xin

Xia, Xiaoshuang
Funding

Funding for this research was provided by:

Projects of Tianjin Municipal Health Commission (TJWJ2024XK008, TJWJ2024XK008, TJWJ2024XK008, TJWJ2024XK008)

the Tianjin Key Tianjin Municipal Science and Technology Bureau Project (21JCZDJC01230, 21JCZDJC01230, 21JCZDJC01230, 21JCZDJC01230)

the National Natural Science Foundation of China (42275197, 42275197, 42275197, 42275197)
License Information

Text and Data Mining valid from 2025-07-22

Version of Record valid from 2025-07-22
More Information

Article History

Received: 22 May 2025

Accepted: 5 July 2025

First Online: 22 July 2025

Declarations

:

: The CHARLS has been cleared by Peking University Biomedical Ethics Review Board, with all individuals offering informed agreement.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below